Aspire Biopharma Warrant (ASBPW)

• Market cap: $316K
• 1 day: -17.09%
• 5 days: -34.5%
• 1 month: -39.91%
• 3 months: -23.39%
• 6 months: -43.53%
• Year to date: -29.57%
• 1 year: -81.29%
• 5 years: -96.26%
• 10 years: -96.26%
• Sector: Healthcare
• Industry: Biotechnology

About: Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.